



Markets
/
Stocks
/
nasdaq-rmd
/

Resmed Inc

RMD

View Detailed Chart

235.500USD

-0.379-0.16%

Market hours （ET）Quotes delayed by 15 min

34.53BMarket Cap

27.65P/E TTM



Resmed Inc

235.500

-0.379-0.16%

Company

Intraday

30m

Today

-0.16%

5 Days

+11.68%

1 Month

+6.94%

6 Months

-4.59%

Year to Date

+2.98%

1 Year

+8.00%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 19 analysts

BUY

Current Rating

260.563

Target Price

10.46%

Rising Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Resmed Inc

RMD

Boston Scientific Corp

BSX

Thermo Fisher Scientific Inc

TMO

Edwards Lifesciences Corp

Intuitive Surgical Inc

ISRG

Veeva Systems Inc

VEEV

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Buy

Sell(1)

Neutral(2)

Buy(7)

Indicators

Sell(1)

Neutral(2)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

6.844

Neutral

RSI(14)

60.027

Neutral

STOCH(KDJ)(9,3,3)

84.697

Overbought

ATR(14)

9.610

Low Volatility

CCI(14)

150.903

Buy

Williams %R

14.594

Overbought

TRIX(12,20)

-0.145

Sell

StochRSI(14)

88.844

Overbought

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

226.928

Buy

MA10

219.841

Buy

MA20

217.049

Buy

MA50

228.470

Buy

MA100

234.039

Buy

MA200

230.480

Buy

News

More news coming soon, stay tuned...

Company

ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.

Company codeRMD

CompanyResmed Inc

CEOMr. Michael J. (Mick) Farrell

Websitehttps://www.resmed.com/